Long-Term Survival After CABG
Patients who undergo CABG can expect a median life expectancy of approximately 17-18 years after surgery, with 10-year survival rates of 77-78%, 20-year survival of 39-47%, and 30-year survival of 14-15%.
Survival Benchmarks
The most robust long-term data comes from multiple cohort studies tracking patients for up to 40 years post-CABG:
- 10-year survival: 77-78% 1, 2, 3
- 20-year survival: 39-47% 1, 2
- 30-year survival: 14-15% 2, 3
- 40-year survival: 4% 1
The overall median life expectancy after CABG ranges from 17.6 to 18.7 years depending on graft type and patient characteristics 1, 2, 4.
Key Factors That Determine Survival
Age at Surgery
Age is the most powerful predictor of long-term mortality. Patients younger than 65 years have dramatically better outcomes, with 88% survival at 10 years and 60% survival at 20 years 5. Each additional year of age increases mortality risk by approximately 4% (HR: 1.04 per year) 2. Patients ≥65 years have nearly 5-fold higher mortality risk (adjusted HR: 4.99) 5.
Extent of Coronary Disease
The number of diseased vessels directly impacts life expectancy 2:
- Single-vessel disease: 21.4 years life expectancy
- Two-vessel disease: 18.8 years life expectancy
- Three-vessel disease: 15.4 years life expectancy
Left main disease independently increases mortality risk by 60% (HR: 1.6) 2.
Left Ventricular Function
Impaired ejection fraction reduces life expectancy by approximately 5 years (13.9 vs 19.3 years with normal function, HR: 1.8) 2. Severe ventricular dysfunction more than doubles mortality risk (adjusted HR: 2.20) 5.
Diabetes and Obesity
Diabetes is an independent predictor of mortality, particularly when combined with obesity (adjusted HR: 1.35) 5. Diabetes alone increases mortality by 28-40% 5. Notably, obesity without diabetes does not independently predict mortality 5.
Graft Type
Total arterial revascularization provides superior long-term survival compared to venous grafts. Mean survival with total arterial grafts is 18.7 years versus 16.1 years with mixed grafts and only 10.4 years with venous grafts alone 4.
Comparison to General Population
Recent evidence demonstrates that elderly CABG patients (>70 years) actually have better survival than the age-matched general population after the first postoperative year (HR: 0.88), with this advantage becoming visible after year one and persisting long-term 6. Similarly, patients with stable three-vessel disease and normal ejection fraction who undergo elective CABG show improved survival compared to age- and sex-matched U.S. population controls, with this relative survival advantage increasing over time 7.
However, a Danish nationwide study showed more nuanced results: mortality risk is substantially elevated in the first 30 days (13.5-fold higher than general population), normalizes somewhat between 31 days and 10 years (HR: 1.09-1.15), but then increases again after 10 years (HR: 1.62 at 11-20 years, HR: 1.76 at 21-30 years) 3.
Temporal Mortality Patterns
The risk of death is not uniform across the post-CABG timeline 3:
- 0-30 days: 3.2% mortality (highest risk period)
- 31-364 days: 2.9% mortality
- 1-10 years: 30.7% cumulative mortality
- 11-20 years: 51.1% cumulative mortality
- 21-30 years: 62.4% cumulative mortality
Need for Repeat Revascularization
The majority of CABG patients require repeat intervention during their lifetime. Between 36-57% of patients undergo repeat revascularization procedures over long-term follow-up 1, 2, underscoring that CABG is a palliative rather than curative treatment for progressive coronary disease 2.
Critical Modifiable Factor: Smoking Cessation
Smoking cessation after CABG produces the largest mortality reduction of any post-operative intervention 8. Patients who quit smoking after CABG have 10-year survival rates of 82% versus only 77% for continued smokers, with 5-year mortality rates of 15% versus 22% respectively (RR: 1.55) 8. The mortality benefit appears within the first year of cessation (RR: 0.63) and persists for decades 8.
Additional High-Risk Features
Other independent predictors of mortality include 5:
- NYHA Class III-IV symptoms (HR: 1.57)
- Preoperative dialysis (HR: 3.13)
- Redo surgery (HR: 3.04)
- Chest re-exploration (HR: 2.14)